Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03834506 | Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) | completed | Phase 3 | 1,030 | Merck Sharp & Dohme LLCINDUSTRY | 21 | Jul 18, 2025 | clinicaltrials |
| NCT05547386 | 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 163 | Mayo ClinicOTHER | 1 | Jul 18, 2025 |
| clinicaltrials |
| NCT03448458 | Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer | completed | Phase 2 | 17 | Emory UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT02430480 | Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2025 | clinicaltrials |
| NCT03963739 | Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer(PCW) | completed | — | 255 | Wake Forest University Health SciencesOTHER | 2 | Jul 16, 2025 | clinicaltrials |
| NCT07069465 | Pilot Study: Androgen Deprivation Therapy Impact on PSMA-PET Sensitivity in Prostatectomy Staging(PIONEER PSMA) | completed | Early Phase 1 | 10 | Urology Clinics of North TexasNETWORK | 1 | Jul 16, 2025 | clinicaltrials |
| NCT02204072 | BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC) | completed | Phase 1 | 120 | Boehringer IngelheimINDUSTRY | 8 | Jul 15, 2025 | clinicaltrials |
| NCT04742361 | Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer | completed | Phase 3 | 136 | ABX advanced biochemical compounds GmbHINDUSTRY | 3 | Jul 15, 2025 | clinicaltrials |
| NCT05877144 | LiSWT for Nerve Sparing Radical Prostatectomy ED | completed | N/A | 8 | Thomas Jefferson UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT02242773 | MRI Based Active Selection for Treatment Trial(MAST) | completed | N/A | 208 | University of MiamiOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT02803437 | Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases | completed | — | 334 | BayerINDUSTRY | 1 | Jul 10, 2025 | clinicaltrials |
| NCT04827446 | Lighting Intervention for Cancer-related Fatigue | completed | N/A | 139 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT00923104 | An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin | completed | — | 61 | National Cancer Institute (NCI)NIH | 1 | Jul 8, 2025 | clinicaltrials |
| NCT03162003 | Irish Programme for Stratified Prostate Cancer Therapy(iPROSPECT) | completed | — | 55 | Cancer Trials IrelandNETWORK | 1 | Jul 8, 2025 | clinicaltrials |
| NCT04621500 | Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans(VitD/RNA-seq) | completed | Phase 2 | 60 | Medical University of South CarolinaOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT06902441 | Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database | completed | — | 52,000 | University Hospital, CaenOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT03741335 | GET FIT Prostate: A Randomized Controlled Exercise Trial | completed | N/A | 284 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT06199986 | DeADT - Living Well With Prostate Cancer(DeADT-LW) | completed | N/A | 50 | University of MichiganOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT03149861 | Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR(PSMA-DOCS) | completed | N/A | 56 | University Health Network, TorontoOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT03982095 | Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate Cancer(PCa_LS) | completed | — | 40 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 20, 2025 | clinicaltrials |
| NCT03315871 | Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2025 | clinicaltrials |
| NCT04400656 | PROState Pathway Embedded Comparative Trial(IP3-PROSPECT) | completed | — | 139 | Imperial College LondonOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT02903368 | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | completed | Phase 2 | 118 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT04100018 | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer(CheckMate 7DX) | completed | Phase 3 | 1,030 | Bristol-Myers SquibbINDUSTRY | 28 | Jun 12, 2025 | clinicaltrials |
| NCT05253053 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 84 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Jun 12, 2025 | clinicaltrials |
| NCT03072238 | Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer(IPATential150) | completed | Phase 3 | 1,101 | Hoffmann-La RocheINDUSTRY | 26 | Jun 6, 2025 | clinicaltrials |
| NCT00667069 | Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | completed | Phase 3 | 424 | UNICANCEROTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT02957149 | Platelet Rich Plasma During Radical Prostatectomy | completed | N/A | 24 | Mayo ClinicOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT04853914 | Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound. | completed | N/A | 9 | EDAP TMS S.A.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
| NCT07006779 | Effects of Music and Conversation in Prostate Biopsy(TRUS-BX) | completed | N/A | 90 | Bozok UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT05735652 | An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel | completed | — | 14 | Boston Scientific CorporationINDUSTRY | 1 | May 30, 2025 | clinicaltrials |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | completed | Phase 1 / Phase 2 | 89 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | May 29, 2025 | clinicaltrials |
| NCT06312670 | Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer | completed | Phase 2 | 13 | Pedro Barata, MD, MScOTHER | 1 | May 29, 2025 | clinicaltrials |
| NCT05801965 | A Digital Therapeutic Solution for Cancer Patients | completed | N/A | 48 | Sidekick HealthINDUSTRY | 1 | May 25, 2025 | clinicaltrials |
| NCT05065944 | Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center | completed | — | 106 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT04890314 | Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment(PC-CONCEPT) | completed | — | 1,953 | Weill Medical College of Cornell UniversityOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT06984159 | The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. | completed | Phase 3 | 137 | Changchun GeneScience Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 22, 2025 | clinicaltrials |
| NCT06389695 | Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients | completed | Phase 1 / Phase 2 | 20 | Norroy Bioscience Co., LTDINDUSTRY | 1 | May 21, 2025 | clinicaltrials |
| NCT03834519 | Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)(KEYLYNK-010) | completed | Phase 3 | 793 | Merck Sharp & Dohme LLCINDUSTRY | 20 | May 18, 2025 | clinicaltrials |
| NCT00328614 | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer | completed | Phase 1 | 32 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 16, 2025 | clinicaltrials |
| NCT04390880 | 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer(PROSPYL) | completed | Phase 2 | 239 | VA Greater Los Angeles Healthcare SystemFED | 1 | May 16, 2025 | clinicaltrials |
| NCT01420250 | Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer | completed | Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT02788773 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | completed | Phase 2 | 52 | Canadian Cancer Trials GroupNETWORK | 1 | May 15, 2025 | clinicaltrials |
| NCT03807492 | Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) | completed | — | 241 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT03987217 | Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients | completed | Early Phase 1 | 73 | University of UtahOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT05671094 | Implementation of a Multimodal Prehabilitation Program in Robotic Oncological Surgery | completed | N/A | 21 | Jessa HospitalOTHER | 1 | May 14, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jul 18, 2025source: clinicaltrials